BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7128652)

  • 1. Bile flow and biliary sulfobromophthalein sodium excretion in rats with liver cirrhosis and portacaval shunt.
    Zsigmond G; Bodnár A; Schaff Z; Karácsonyi S
    Eur Surg Res; 1982; 14(5):344-57. PubMed ID: 7128652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of portocaval shunt on bile flow and maximal biliary excretion of bromsulfophthalein sodium (BSP) in rats with thioacetamide induced liver cirrhosis.
    Bodnár A; Karácsonyi S; Zsigmond G
    Z Exp Chir; 1981 Feb; 14(1):35-9. PubMed ID: 7234017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic organic anion transport following portacaval shunt in patients with cirrhosis.
    Zsigmond GL; Bodnár A; Karácsonyi S
    Acta Chir Hung; 1984; 25(2):97-106. PubMed ID: 6464621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of portacaval shunting on hyperdynamic circulation in bile duct-ligated cirrhotic rats.
    Wong J; Zhang Y; Lee SS
    J Hepatol; 1997 Feb; 26(2):369-75. PubMed ID: 9059959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic biliary drainage corrects liver atrophy induced by portacaval shunt in the rat.
    Bioulac P; Dubuisson L; Saric J; Despuyoos L; Bedin C; Magne F; Balabaud C
    Gastroenterology; 1981 May; 80(5 pt 1):1023-30. PubMed ID: 6781976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile canaliculi morphology after bile duct ligation in the rat with portacaval shunt: a time course study.
    Vital A; Bioulac-Sage P; Bedin C; Balabaud C
    Liver; 1982 Sep; 2(3):230-5. PubMed ID: 7176848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of sodium taurocholate on the hepatic metabolism of sulfobromophthalein sodium (BSP). The role of bile flow.
    Boyer JL; Scheig RL; Klatskin G
    J Clin Invest; 1970 Feb; 49(2):206-15. PubMed ID: 5411780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic functional deterioration after portacaval shunt in the rat. Effects on sulfobromophthalein transport-maximum, indocyanine green clearance and galactose elimination capacity.
    Lauterburg BH; Sautter V; Preisig R; Bircher J
    Gastroenterology; 1976 Aug; 71(2):221-7. PubMed ID: 939381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximal biliary transport of sulfobromophthalein in patients with a T-tube placed in the common bile duct.
    Serra MA; Caballero A; Del Olmo JA; Aparisi L; Gilabert MS; Rodríguez F; Escudero A; Wassel A; Ferrando J; Reig G; Rodrigo JM
    Eur J Drug Metab Pharmacokinet; 1997; 22(2):135-9. PubMed ID: 9248781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporary beneficial effect of arterialization of the liver in cirrhotic dogs with a portacaval shunt. A preliminary report.
    Terpstra OT; van Vroonhoven TJ; Noordhoek J; ten Kate FJ; Wilson JH
    Eur Surg Res; 1982; 14(5):333-43. PubMed ID: 7128651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of bile flow and inhibition of biliary secretion of taurocholate and leukotriene C4 in thioacetamide-induced liver fibrosis.
    Müller D; Dietze E; Dargel R; Krell H
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():16-9. PubMed ID: 7483705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of end to side and side to side portacaval shunts in dogs and human subjects with cirrhosis and portal hypertension.
    Orloff MJ; Chandler JG; Charters AC; Condon JK; Grambort DE; Modafferi TR; Levin SE
    Am J Surg; 1974 Aug; 128(2):195-201. PubMed ID: 4843863
    [No Abstract]   [Full Text] [Related]  

  • 13. Separate transport systems for biliary secretion of sulfated and unsulfated bile acids in the rat.
    Kuipers F; Enserink M; Havinga R; van der Steen AB; Hardonk MJ; Fevery J; Vonk RJ
    J Clin Invest; 1988 May; 81(5):1593-9. PubMed ID: 3366909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental liver arterialization following portacaval shunt - rehabilitation].
    Hirner A; Häring R
    Chirurg; 1981 Jun; 52(6):389-97. PubMed ID: 7249857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary excretion of bile acids and organic anions in rats with dichloroethylene-induced bile canalicular injury.
    Marumo T; Fukusato T; Takikawa H
    J Gastroenterol; 2004 Oct; 39(10):981-7. PubMed ID: 15549452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic organic anion transport kinetics and bile flow during short-term total parenteral nutrition in the rabbit.
    Das JB; Ghosh S; Cosentino CM; Ansari GG
    Proc Soc Exp Biol Med; 1990 Nov; 195(2):274-8. PubMed ID: 2122468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible impairment of neonatal hepatobiliary function by maternal cholestasis.
    Monte MJ; Morales AI; Arevalo M; Alvaro I; Macias RI; Marin JJ
    Hepatology; 1996 May; 23(5):1208-17. PubMed ID: 8621155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of cholic acid and dehydrocholic acid on the biliary excretion of unconjugated and conjugated sulfobromophthalein in rats.
    Schulze PJ; Czok G; Meyer H
    Arzneimittelforschung; 1976; 26(10):1894-903. PubMed ID: 1037210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilirubin as a cholestatic agent. IV. Effect of bilirubin and sulfobromophthalein (BSP) on biliary manganese excretion.
    Witzleben CL; Boyce WH
    Arch Pathol; 1975 Sep; 99(9):496-8. PubMed ID: 1164253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does flow-limited portal arterialization avoid the disadvantages of portacaval shunts in healthy and cirrhotic rats? (author's transl)].
    Hirner A; Häring R; Karavias T
    Chir Forum Exp Klin Forsch; 1980; ():155-9. PubMed ID: 7389447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.